News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,942 Results
Type
Article (1611)
Company Profile (21)
Press Release (67310)
Section
Business (30364)
Career Advice (40)
Deals (4965)
Drug Delivery (2)
Drug Development (7460)
Employer Resources (9)
FDA (1210)
Job Trends (1740)
News (41788)
Policy (2120)
Tag
Academia (130)
Adcomms (1)
Allergies (11)
Alliances (2390)
ALS (10)
Alzheimer's disease (128)
Antibody-drug conjugate (ADC) (39)
Approvals (1277)
Artificial intelligence (25)
Autoimmune disease (13)
Automation (4)
Bankruptcy (12)
Best Places to Work (1674)
BIOSECURE Act (1)
Biosimilars (15)
Biotechnology (10)
Bladder cancer (25)
Brain cancer (4)
Breast cancer (87)
Cancer (660)
Cardiovascular disease (52)
Career advice (38)
Career pathing (1)
CAR-T (20)
CDC (2)
Cell therapy (55)
Cervical cancer (5)
Clinical research (7111)
Collaboration (96)
Company closure (1)
Compensation (180)
Complete response letters (2)
COVID-19 (186)
CRISPR (6)
C-suite (39)
Cystic fibrosis (10)
Data (906)
Depression (9)
Diabetes (41)
Diagnostics (682)
Digital health (7)
Diversity, equity & inclusion (4)
Drug discovery (16)
Drug pricing (6)
Duchenne muscular dystrophy (8)
Earnings (28836)
Editorial (1)
Employer resources (8)
Events (7677)
Executive appointments (20)
FDA (1724)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (7)
Funding (60)
Gene editing (9)
Generative AI (2)
Gene therapy (29)
GLP-1 (84)
Government (271)
Grass and pollen (1)
Guidances (263)
Healthcare (2016)
HIV (8)
Huntington's disease (3)
IgA nephropathy (11)
Immunology and inflammation (24)
Immuno-oncology (5)
Indications (22)
Infectious disease (218)
Inflammatory bowel disease (21)
Influenza (11)
Intellectual property (12)
Interviews (1)
IPO (3921)
IRA (3)
Job creations (165)
Job search strategy (37)
JPM (3)
Kidney cancer (3)
Labor market (6)
Layoffs (23)
Legal (290)
Liver cancer (6)
Longevity (1)
Lung cancer (110)
Lymphoma (102)
Machine learning (2)
Management (3)
Manufacturing (36)
MASH (43)
Medical device (1653)
Medtech (1659)
Mergers & acquisitions (1168)
Metabolic disorders (139)
mRNA (4)
Multiple sclerosis (18)
NASH (3)
Neurodegenerative disease (22)
Neuropsychiatric disorders (8)
Neuroscience (228)
NextGen: Class of 2026 (494)
Non-profit (255)
Now hiring (3)
Obesity (53)
Opinion (8)
Ovarian cancer (18)
Pain (13)
Pancreatic cancer (30)
Parkinson's disease (26)
Partnered (3)
Patents (16)
Patient recruitment (29)
Peanut (2)
People (1962)
Pharmaceutical (9)
Pharmacy benefit managers (2)
Phase 1 (1863)
Phase 2 (2974)
Phase 3 (2864)
Pipeline (1595)
Policy (10)
Postmarket research (241)
Preclinical (471)
Press Release (1)
Prostate cancer (28)
Radiopharmaceuticals (27)
Rare diseases (66)
Real estate (224)
Recruiting (2)
Regulatory (1891)
Reports (7)
Research institute (251)
Resumes & cover letters (1)
Rett syndrome (5)
RSV (11)
Schizophrenia (16)
Series A (6)
Series B (2)
Service/supplier (1)
Sickle cell disease (8)
Special edition (4)
Spinal muscular atrophy (14)
Sponsored (4)
Startups (121)
Stomach cancer (2)
Supply chain (2)
Tariffs (5)
The Weekly (2)
Vaccines (55)
Venture capital (2)
Weight loss (35)
Women's health (11)
Date
Today (12)
Last 7 days (108)
Last 30 days (472)
Last 365 days (4321)
2026 (680)
2025 (4355)
2024 (4779)
2023 (5429)
2022 (6340)
2021 (7343)
2020 (6563)
2019 (4537)
2018 (3551)
2017 (3035)
2016 (2102)
2015 (3114)
2014 (2089)
2013 (1410)
2012 (1618)
2011 (1780)
2010 (1634)
Location
Africa (41)
Alabama (18)
Arizona (20)
Asia (4507)
Australia (317)
California (1816)
Canada (408)
China (125)
Colorado (72)
Connecticut (72)
Delaware (58)
Europe (9105)
Florida (234)
Georgia (62)
Idaho (2)
Illinois (91)
India (7)
Indiana (82)
Iowa (5)
Japan (43)
Kansas (7)
Kentucky (8)
Louisiana (9)
Maine (15)
Maryland (206)
Massachusetts (1161)
Michigan (31)
Minnesota (117)
Missouri (8)
Montana (4)
Nebraska (2)
Nevada (10)
New Hampshire (11)
New Jersey (578)
New Mexico (1)
New York (363)
North Carolina (196)
North Dakota (1)
Northern California (965)
Ohio (47)
Oregon (11)
Pennsylvania (350)
Puerto Rico (1)
Rhode Island (2)
South America (79)
Southern California (724)
Tennessee (20)
Texas (200)
United States (5941)
Utah (48)
Virginia (16)
Washington D.C. (6)
Washington State (109)
Wisconsin (10)
68,942 Results for "62".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
February 12, 2026
·
4 min read
Press Releases
U.S. Bispecific Antibody Market to Worth USD 448.62 Billion by 2035
December 3, 2025
·
1 min read
Press Releases
Detalimogene Demonstrates Improved Complete Response Rate of 62% at 6 Months
November 11, 2025
·
13 min read
Cancer
Cardiff Craters Amid Executive Exits, Mixed Mid-Stage Data
Onvansertib cut the risk of death or disease progression by 62% versus standard of care, but analysts await more detailed data.
January 28, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Early Warning Press Release in Accordance with National Instrument 62-103
July 25, 2025
·
2 min read
Press Releases
Early Warning Press Release in Accordance with National Instrument 62-103
July 25, 2025
·
2 min read
Press Releases
Calliditas Therapeutics Presented at the 62nd European Renal Association Congress
June 10, 2025
·
3 min read
Press Releases
U.S. Medical Device Contract Manufacturing Market Size to Hit USD 62.42 Billion by 2034
July 2, 2025
·
1 min read
Press Releases
Travere Therapeutics to Present New FILSPARI® (sparsentan) Data at the 62nd ERA Congress
June 4, 2025
·
17 min read
Press Releases
GLP-1 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034
July 14, 2025
·
1 min read
1 of 6,895
Next
